Coronavirus Pseudovirus Packaging for Safe Disinfectant Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of effective methods for evaluating the efficacy of virucidal disinfectants against highly transmissible and harmful viruses like SARS-CoV-2, SARS-CoV, and MERS-CoV, due to the absence of standardized biological safety tests, which hinders the application and optimization of disinfection technologies.
Innovation Solution
A coronavirus pseudovirus packaging system using a replication-defective vesicular stomatitis virus (VSV) with dual-reporter genes and packaging cells expressing coronavirus spike proteins, enabling a one-step packaging method to produce pseudoviruses that simulate wild virus infection, allowing safe and efficient evaluation of disinfection methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If live viruses are used for evaluation, then the evaluation results are accurate and reliable, but biological safety risks increase and require P3 laboratory conditions
Solution Approach 1:
The patent creates a pseudovirus system that copies the essential infection characteristics of live coronaviruses (SARS-CoV-2, SARS-CoV, MERS-CoV) by incorporating their spike proteins into a VSV backbone. This pseudovirus model replicates the entry and infection mechanisms of authentic viruses while being replication-defective, thereby maintaining evaluation accuracy without the biosafety risks of live viruses requiring P3 laboratory conditions
2Adaptability or versatility
If standardized evaluation methods are established, then disinfection technology application is promoted, but complex packaging and production systems are required
Solution Approach 1:
The patent divides the pseudovirus production system into distinct functional modules: a VSV-based replication-defective backbone, separate spike protein expression plasmids for different coronaviruses, and standardized packaging cell lines. This segmentation allows the system to be adapted to evaluate multiple coronavirus types and various disinfection methods while maintaining a consistent production framework, thus promoting standardization without excessive complexity
Solution Approach 2:
The pseudovirus packaging system is designed with universal applicability through the use of a common VSV backbone that can accommodate spike proteins from multiple coronavirus species (SARS-CoV-2, SARS-CoV, MERS-CoV). The system can evaluate various disinfection approaches including chemical disinfectants, physical treatments, and antibody neutralization, making it a multi-functional platform that standardizes evaluation across diverse scenarios without requiring separate complex systems for each application
Data Source
AI summary
A packaging system for a coronavirus pseudovirus, including a vesicular stomatitis virus (VSV) vector in which Fluc and EGFP dual-reporter genes replace a GP gene, and packaging cell that expresses a coronavirus spike protein. The packaging system may quickly package pseudoviruses by using a one-step packaging method, and may be used in the research of coronaviruses such as COVID-19 (SARS-CoV-2), SARS (SARS-CoV) and MERS, and other viruses. The packaging system and thereby pseudovirus method may also be used to evaluate the efficacy of disinfectants by means of virus contamination distribution models, setting up scenarios, and sampling and testing steps.